-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Today, more than a year has passed since the outbreak of the new crown pneumonia, and after entering August, the cumulative number of patients with new crown pneumonia worldwide has reached more than 200 million
Important news from the Chinese team
However, it is worth noting that under such unfavorable circumstances, China has recently received good news
According to its data introduction, the neutralizing activity IC50 of this antibody against this virus can reach 5ng/ml.
According to reports from relevant media reporters on the 4th of this month, Shenzhen Kangtai Biotech’s previous vaccine research and development projects were mainly targeted at mutant strains of the new coronavirus
Under such circumstances, the corresponding evaluation of the virus strain will be carried out in the follow-up, the follow-up research work will be carried out in accordance with the relevant requirements of the vaccine, and the mutant strains used in the vaccine will be screened, so that the targeted new coronavirus mutant strains will be eliminated.
Discover antibodies against mutant viruses
According to relevant news, the previous "Kovic" new crown vaccine has been approved and has been successfully put into emergency use, and this vaccine also has a good performance in dealing with the mutant strain of the new crown virus
In fact, as the delta mutant virus continues to spread, its traces have been found in our country before